New medical technology can be exciting, but innovation alone is not enough. Before it reaches patients, it must be safe, effective and ready for responsible use.
That is where clearance from the Food and Drug Administration becomes important. For many medical devices, FDA clearance is the point where years of development, testing and refinement begin moving into clinical use.
That review process is especially important in spine care, where implants and instruments must support the body through movement, healing and recovery. A new implant or surgical tool may spend months or years in design before it is ready for patients. FDA clearance helps create a framework for that transition, giving companies, physicians and patients confidence that a technology has met required standards before entering the market.
That confidence has business implications as well as clinical ones. Once a device is cleared, companies can begin commercial rollout, physician training, inventory planning and market education. Surgeons can evaluate how the technology fits into practice, while healthcare organizations consider how it may support patient care, efficiency and long-term outcomes.
For regions like Arizona, physician involvement in this process reflects a mature healthcare market. It shows how local medical leaders are not only treating patients but also helping assess which technologies are ready for responsible adoption.
That is vital for specialties like spine care, where new technology can be expensive, highly specialized and difficult for patients to evaluate. FDA clearance does not mean every patient needs a new device, but it helps qualified physicians bring appropriate tools into care when they can make a meaningful difference.
For patients, the value is trust. For healthcare leaders, FDA clearance signals readiness, allowing companies and care teams to move from development to responsible adoption with greater confidence and a clearer focus on patient outcomes.
Keven Burns, M.D., a spine surgeon at Spine Institute of Arizona in Scottsdale, served as one of the design surgeons for the newly FDA-approved 3D-printed titanium ALIF cage (Ventana-A). Over the past 18 months, he worked directly with Spinal Elements’ biomedical engineering team to refine the implant design and surgical instrumentation prior to FDA clearance.
Editor’s Note: This is the final article of a three-part series from Dr. Burns.
